إعلان
إعلان
OLMA
Olema Pharmaceuticals, Inc. Common Stock
28.08
USDبرعاية
+2.51
+9.83%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
28.18
+0.10
+0.36%
تقارير أرباح OLMA
النسبة الإيجابية المفاجئة
OLMA تفوق 11 من 20 آخر التقديرات.
55%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.55
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+12.24%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+7.84%
Olema Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ١٠ نوفمبر ٢٠٢٥, OLMA reported earnings of -0.49 USD per share (EPS) for Q3 25, beating the estimate of -0.49 USD, resulting in a 0.67% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 المحللين forecast an EPS of -0.55 USD, with revenue projected to reach -- USD, implying an زيادة of 12.24% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Olema Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Olema Pharmaceuticals, Inc. Common Stock reported EPS of -$0.49, beating estimates by 0.67%, and revenue of $0.00, 0% as expectations.
How did the market react to Olema Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.19%, changed from $8.35 before the earnings release to $8.70 the day after.
When is Olema Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for Olema Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 11
المحللين, Olema Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.55 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان